Venus Remedies shares rose 6% after winning a UNICEF tender for its antibiotic drug Ceftriaxone 1 mg.

Venus Remedies shares rose 6% after the company won a tender from UNICEF for its antibiotic drug Ceftriaxone 1 mg, following GMP approval from UNICEF. The stock traded at ₹374.50 on the NSE, up 5.69%. This win comes after Venus Remedies secured a contract for supplying its antibiotic product Ceftriaxone in the Beta Lactam tender, with UNICEF.